TRIQ Healthcare UK Ltd.
TRIQ Healthcare UK Ltd. leverages decades of expertise in medical device research to drive healthcare innovation. Our mission is to bring groundbreaking treatments and novel medical devices to the UK market, aiming to deliver exceptional patient care, enhance quality of life, and alleviate the cost burden on the NHS. With a commitment to addressing unmet medical needs, we are dedicated to advancing healthcare outcomes across the nation.
Zero emissions by 2050
TRIQ Group is committed to creating a comprehensive Carbon Reduction Plan that aligns with our goal of building a sustainable healthcare system. This initiative targets reducing carbon emissions across all operations, from product development to supply chains, to enhance public health and environmental sustainability while adhering to UK governmental requirements. TRIQ Group is dedicated to minimizing its environmental impact while delivering high-quality healthcare solutions by adopting innovative technologies, optimising energy use, and promoting sustainable practices. We are committed to achieving net zero emissions by 2050, reflecting our broader responsibility to protect the planet for future generations and improve overall health and well-being.
Modern Slavery Act 2015
TRIQ Group is fully committed to the principles outlined in the Modern Slavery Act of 2015 and voluntarily supports its goals to eradicate all forms of modern slavery and human trafficking. We recognize our responsibility to ensure that our business operations and supply chains are free from these unethical practices. To this end, TRIQ Group is dedicated to conducting thorough due diligence, implementing robust policies, and maintaining ongoing monitoring to ensure compliance among our suppliers. We will do our utmost to ensure that all partners and suppliers uphold the highest ethical standards, reflecting our commitment to human rights and fair labour practices across all aspects of our business.
Our Products
TRIQ Healthcare partners with innovative small companies & start-ups to deliver unique treatment solutions to patients across the UK. Through these collaborations, we aim to introduce cutting-edge therapies that address unmet medical needs, enhance patient care, improve health outcomes and enhance quality of life nationwide.
- Dr. INVIVO, Autologous, AI-assisted, 3D Skin Regeneration system, Single treatment for complex wounds, Diabetic Foot Ulcers, Burn wounds, Cancer resection wounds & Trauma wounds. Because the patients’ own tissue is modified to enhance the wound healing, there is no risk of adverse reactions or rejection.
- Dr. INVIVO Brochure
- Safety UV is an advanced ultraviolet disinfecting system designed to combat airborne and surface bacteria and viruses effectively. This innovative solution provides continuous disinfection, making it particularly valuable during influenza and COVID-19 outbreaks. Safety UV is ideal for use in hospital waiting areas, ICUs, GP waiting rooms, reception areas, nursing homes, and any public spaces or transport environments where the risk of cross-contamination is high. By offering round-the-clock protection, Safety UV helps to create safer, healthier spaces for both patients and the public.
- Safety UV Brochure
Study Documents
Our products have been rigorously tested for efficacy and safety. They have been awarded the CE Mark for Medical Products under 2017/745 MDR and are MHRA registered. Here, you can find the publications of numerous studies conducted worldwide, test reports, and other supporting documentation.